Written Question·Department of Health and Social Care·UIN HL15136

Prescription Drugs: Cost Effectiveness

Tabled: 3 March 2026
Answered: 11 March 2026

Question

To ask His Majesty's Government what assessment they have made of the number of National Institute for Health and Care Excellence appraisals which are paused pending increases in the cost per quality-adjusted life year threshold in April.

Answer

There are currently two appraisals paused, at the request of the company, until the National Institute for Health and Care Excellence (NICE) has the power to apply the new cost-effectiveness threshold:Vorasidenib for treating astrocytoma or oligodendrogli...
ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN HL15136) →